The S&P/ASX 200 Index (ASX: XJO) is having a decent day of trading on the markets this Tuesday so far, nicely countering yesterday's shaky start to the trading week. At the time of writing, the ASX 200 is up a healthy 0.75% at 7,347 points.
But let's dive a little deeper and check out the ASX 200 shares topping the share market's volume charts this afternoon, according to investing.com.
3 most traded ASX 200 shares by volume on Tuesday
Santos Ltd (ASX: STO)
Santos is first up today. This ASX 200 energy share has seen a hefty 9.82 million of its shares find new homes so far this Tuesday. With no news or announcements out of the company thus far, we can probably assume that this elevated volume is the result of the movements in the Santos share price itself. Some speculation regarding potential divestment of assets may also be contributing. Santos shares are currently up a pleasing 1.3% so far today to $6.19 a share.
Pilbara Minerals Ltd (ASX: PLS)
ASX 200 lithium producer Pilbara is our next cab off the rank. Pilbara has had a sizeable 39.88 million of its shares bought and sold thus far today. This has no doubt been initiated by the rather large share price plunge Pilbara has endured today. This company's shares are presently down a very nasty 11.2% at $2.45 each. This looks to be related to the company's production and shipping guidance downgrade it unloaded on investors this morning.
Imugene Limited (ASX: IMU)
Our final and most traded ASX 200 share thus far today is biotech company Imugene. Imugene has had a whopping 50.96 million of its shares swap owners so far on Tuesday. Despite this massive volume, there's not much going on with this company today. There has been no major (or any) news or announcements out of the company.
However, the Imugene share price is having what could be described as a pretty solid day of trading. Its shares are currently up a robust 1.2% at 42 cents each. This move may have sparked so many shares to be traded today. Or perhaps there were one or two unusually large trades. Whatever the reason, Imugene is, at least for now, the ASX 200's most traded share this Tuesday.
